Literature DB >> 17989880

Sequestration of glyceraldehyde-3-phosphate dehydrogenase to aggregates formed by mutant huntingtin.

Junchao Wu1, Fang Lin, Zhenghong Qin.   

Abstract

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has been reported to interact with proteins containing the polyglutamine (polyQ) domain. The present study was undertaken to evaluate the potential contributions of the polyQ and polyproline (polyP) domains to the co-localization of mutant huntingtin (htt) and GAPDH. Overexpression of N-terminal htt (1-969 amino acids) with 100Q and 46Q (htt1-969-100Q and httl-969-46Q, mutant htt) in human mammary gland carcinoma MCF-7 cells formed more htt aggregates than that of htt1-969-18Q (wild-type htt). The co-localization of GAPDH with htt aggregates was found in the cells expressing mutant but not wild-type htt. Deletion of the polyP region in the N-terminal htt had no effect on the co-localization of GAPDH and mutant htt aggregates. These results suggest that the polyQ domain, but not the polyP domain, plays a role in the sequestration of GAPDH to aggregates by mutant htt. This effect might contribute to the dysfunction of neurons caused by mutant htt in Huntington's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17989880     DOI: 10.1111/j.1745-7270.2007.00352.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  7 in total

Review 1.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

2.  Glyceraldehyde-3-Phosphate Dehydrogenase Facilitates Macroautophagic Degradation of Mutant Huntingtin Protein Aggregates.

Authors:  Surbhi Chaudhary; Asmita Dhiman; Rahul Dilawari; Gaurav Kumar Chaubey; Sharmila Talukdar; Radheshyam Modanwal; Anil Patidar; Himanshu Malhotra; Chaaya Iyengar Raje; Manoj Raje
Journal:  Mol Neurobiol       Date:  2021-08-18       Impact factor: 5.590

3.  Prion-promoted phosphorylation of heterologous amyloid is coupled with ubiquitin-proteasome system inhibition and toxicity.

Authors:  Zi Yang; David E Stone; Susan W Liebman
Journal:  Mol Microbiol       Date:  2014-08-05       Impact factor: 3.501

4.  IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice.

Authors:  Carla Lopes; Márcio Ribeiro; Ana I Duarte; Sandrine Humbert; Frederic Saudou; Luís Pereira de Almeida; Michael Hayden; A Cristina Rego
Journal:  Mol Neurobiol       Date:  2013-12-18       Impact factor: 5.590

5.  An intrinsically disordered yeast prion arrests the cell cycle by sequestering a spindle pole body component.

Authors:  Sebastian Treusch; Susan Lindquist
Journal:  J Cell Biol       Date:  2012-04-23       Impact factor: 10.539

Review 6.  Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.

Authors:  Chaebin Kim; Ali Yousefian-Jazi; Seung-Hye Choi; Inyoung Chang; Junghee Lee; Hoon Ryu
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

7.  Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease.

Authors:  Sunhee Hwang; Marie-Hélène Disatnik; Daria Mochly-Rosen
Journal:  EMBO Mol Med       Date:  2015-10       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.